Antibodies directed against AQP-4 are characteristically found in patients suffering from neuromyelitis optica (NMO), a demyelinating disease of the CNS that mainly affects the optic nerve and the spinal cord [44]. Here, AQP4 is linked to neuromyelitis optica.